Llwytho...
Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan
Direct oral anticoagulants (DOACs) were developed to compensate for the demerits of warfarin. In Japan, three factor Xa inhibitors are used for the treatment of venous thromboembolism (VTE): edoxaban, rivaroxaban, and apixaban. Despite problems, such as the inability to monitor their effect and the...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Atheroscler Thromb |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Japan Atherosclerosis Society
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5453680/ https://ncbi.nlm.nih.gov/pubmed/28392512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.RV17005 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|